Erratum to Epigenetic mechanisms of chronic pain. [Trends in Neurosciences 38 (2015), 237-246]. doi: 10.1016/j.tins.2015.02.001;Epigenetic mechanisms of chronic pain

Trends in Neurosciences

Volumn 38, Issue 4, 2015, Pages 237-246

  Descalzi, Giannina ^a   Ikegami, Daigo ^b   Ushijima, Toshikazu ^c,d   Nestler, Eric J ^a   Zachariou, Venetia ^a   Narita, Minoru ^b,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOSHI UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d Life Science Tokyo Advanced Research Center (L StaR)   (Japan)

Author keywords

Animal models; HDAC; Histone modifications; Inflammatory pain; Methylation; MiRNA; Neuropathic pain

Indexed keywords

HISTONE DEACETYLASE 1; MICRORNA; HISTONE;

ANALGESIA; BEHAVIOR CHANGE; BRAIN REGION; CHRONIC PAIN; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; INFLAMMATORY PAIN; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; ANIMAL; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; CHRONIC PAIN; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HISTONES; HUMANS;

EID: 84926103731     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2015.07.002     Document Type: Erratum

References (108)

1. Woolf C., Mannion R. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
2. Ji R., et al. Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends Neurosci. 2003, 26:696-705.
3. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1768.
4. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research 2011, Institute of Medicine, The National Academies Press.
5. Mogil J.S. Animal models of pain: progress and challenges. Nat. Rev. Neurosci. 2009, 10:283-294.
6. Basbaum A.I., et al. Cellular and molecular mechanisms of Pain. Cell 2009, 139:267-284.
7. Ikeda H., et al. Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 2006, 312:1659-1662.
8. Sandkuhler J., Liu X. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur. J. Neurosci. 1998, 10:2476-2480.
9. Ji R.R., Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J. Neurosci. 1997, 17:1776-1785.
10. Narita M., et al. Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J. Neurosci. 2005, 25:10000-10009.
11. Wei F.P., et al. Loss of synaptic depression in mammalian anterior cingulate cortex after amputation. J. Neurosci. 1999, 19:9346-9354.
12. Alvarado S., et al. Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex. Mol. Pain 2013, 9:21.
13. Hyman S., Nestler E. The Molecular Foundations of Psychiatry 1993, American Psychiatric Press.
14. Vignes M., Collingridge G.L. The synaptic activation of kainate receptors. Nature 1997, 388:179-182.
15. Kandel E. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
16. Nelson E.D., Monteggia L.M. Epigenetics in the mature mammalian brain: effects on behavior and synaptic transmission. Neurobiol. Learn. Mem. 2011, 96:53-60.
17. Sweatt J.D. The emerging field of neuroepigenetics. Neuron 2013, 80:624-632.
18. Renthal W., et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56:517-529.
19. Robison A.J., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 2011, 12:623-637.
20. Vialou V., et al. Epigenetic mechanisms of depression and antidepressant action. Annu. Rev. Pharmacol. Toxicol. 2013, 53:59-87.
21. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10604-10609.
22. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
23. Jiang Y., et al. Epigenetics in the nervous system. J. Neurosci. 2008, 28:11753-11759.
24. Bienvenu T., Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet. 2006, 7:415-426.
25. Fuks F., et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 2003, 278:4035-4040.
26. Chen W.G., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
27. Géranton S.M., et al. A role for transcriptional repressor methyl-CpG-binding protein 2 and plasticity-related gene serum- and glucocorticoid-inducible kinase 1 in the induction of inflammatory pain states. J. Neurosci. 2007, 27:6163-6173.
28. Geranton S., et al. Descending serotonergic controls regulate inflammation-induced mechanical sensitivity and methyl-CpG-binding protein 2 phosphorylation in the rat superficial dorsal horn. Mol. Pain 2008, 4:35.
29. Kynast K.L., et al. Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice. Pain 2013, 154:368-376.
30. Imai S., et al. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain 2013, 136:828-843.
31. Viet C.T., et al. Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain. Pain 2011, 152:2323-2332.
32. Freitas Cordeiro-Silva M., et al. Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol. Biol. Rep. 2011, 38:5435-5441.
33. Pickering V., et al. Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice. Eur. J. Pain 2008, 12:293-300.
34. Peters C.M., et al. Endothelin and the tumorigenic component of bone cancer pain. Neuroscience 2004, 126:1043-1052.
35. Guan Z., et al. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 2002, 111:483-493.
36. Hart A.K., et al. Serotonin-mediated synapsin expression is necessary for long-term facilitation of the aplysia sensorimotor synapse. J. Neurosci. 2011, 31:18401-18411.
37. Gregoretti I.V., et al. Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J. Mol. Biol. 2004, 338:17-31.
38. Dekker F.J., et al. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov. Today 2014, 19:654-660.
39. Bai G., et al. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol. Pain 2010, 6:51-63.
40. Cherng C-H., et al. Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats. J. Formos. Med. Assoc. 2014, 113:513-520.
41. Winkler I., et al. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain. Br. J. Pharmacol. 2005, 146:198-208.
42. Chiechio S., et al. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol. Pharmacol. 2009, 75:1014-1020.
43. Chiechio S., et al. Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain. Trends Pharmacol. Sci. 2010, 31:153-160.
44. Sima A.A.F., et al. Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 2005, 28:89-94.
45. Scarpini E., et al. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. J. Peripher. Nerv. Syst. 1997, 2:250-252.
46. Chiechio S., et al. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol. Pain 2006, 2:20.
47. Chiechio S., et al. l-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol. Pharmacol. 2002, 61:989-996.
48. Uchida H., et al. Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J. Neurosci. 2010, 30:4806-4814.
49. Kim C.S., et al. Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the μ opioid receptor gene. J. Biol. Chem. 2004, 279:46464-46473.
50. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
51. Pohl K-W., et al. MicroRNA changes in the mouse prefrontal cortex after inflammatory pain. Eur. J. Pain 2011, 15:801.e1-801.e12.
52. Bai G., et al. Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol. Pain 2007, 3:15.
53. Zhao J., et al. Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J. Neurosci. 2010, 30:10860-10871.
54. Sakai A., Suzuki H. Nerve injury-induced upregulation of miR-21 in the primary sensory neurons contributes to neuropathic pain in rats. Biochem. Biophys. Res. Commun. 2013, 435:176-181.
55. Ni J., et al. Regulation of μ-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation. Eur. J. Pain 2013, 17:313-323.
56. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
57. Ito K., et al. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 2000, 20:6891-6903.
58. Yu B., et al. Profile of microRNAs following rat sciatic nerve injury by deep sequencing: implication for mechanisms of nerve regeneration. PLoS ONE 2011, 6:e24612.
59. Shi G., et al. Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia 2013, 61:504-512.
60. Favereaux A., et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J. 2011, 30:3830-3841.
61. Dib-Hajj S.D., et al. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 1999, 83:591-600.
62. Sakai A., et al. miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. Brain 2013, 136:2738-2750.
63. Chen H-P., et al. Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury. Neurochem. Res. 2014, 39:76-83.
64. Li X-Y., et al. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010, 330:1400-1404.
65. Baliki M.N., et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat. Neurosci. 2012, 15:1117-1119.
66. Garcia-Larrea L., Peyron R. Pain matrices and neuropathic pain matrices: a review. Pain 2013, 154(Suppl. 1):S29-S43.
67. Zhuo M. Cortical excitation and chronic pain. Trends Neurosci. 2008, 31:199-207.
68. Narita M., et al. Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 2011, 152:1358-1372.
69. Apkarian A.V., et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 2005, 9:463-484.
70. Hutchison W., et al. Pain-related neurons in the human cingulate cortex. Nat. Neurosci. 1999, 2:403-405.
71. Rainville P., et al. Representation of acute and persistent pain in the human CNS: potential implications for chemical intolerance. Ann. N. Y. Acad. Sci. 2001, 933:130-141.
72. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 2000, 288:1769-1772.
73. Bushnell M.C., et al. Cognitive and emotional control of pain and its disruption in chronic pain. Nat. Rev. Neurosci. 2013, 14:502-511.
74. Neugebauer V., et al. The amygdala and persistent pain. Neuroscientist 2004, 10:221-234.
75. Talbot J., et al. Multiple representations of pain in human cerebral cortex. Science 1991, 251:1355-1358.
76. Derbyshire S.W., et al. Fibromyalgia pain and its modulation by hypnotic and non-hypnotic suggestion: an fMRI analysis. Eur. J. Pain 2009, 13:542-550.
77. Hofbauer R.K., et al. Thermal and tactile sensory deficits and allodynia in a nerve-injured patient: a multimodal psychophysical and functional magnetic resonance imaging study. Clin. J. Pain 2006, 22:104-108.
78. Baliki M.N., et al. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010, 66:149-160.
79. Craig A.D. Pain mechanisms: labeled lines versus convergence in central processing. Annu. Rev. Neurosci. 2003, 26:1-30.
80. Tracey I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
81. Ossipov M.H., et al. Central modulation of pain. J. Clin. Invest. 2010, 120:3779-3787.
82. Porreca F., et al. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002, 25:319-325.
83. Behbehani M.M., Fields H.L. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res. 1979, 170:85-93.
84. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
85. Zhuo M., Gebhart G. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J. Neurophysiol. 1997, 78:746-758.
86. Zhang Z., et al. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat. Med. 2011, 17:1448-1455.
87. Burgess S.E., et al. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 2002, 22:5129-5136.
88. Buhler A.V., et al. Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine. Pain 2008, 135:280-290.
89. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab. Res. Rev. 2008, 24(Suppl. 1):S52-S57.
90. Tajerian M., et al. Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex. PLoS ONE 2013, 8:e55259.
91. Nasca C., et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4804-4809.
92. Bair M.J., et al. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom. Med. 2008, 70:890-897.
93. Purushothaman B., et al. Prevalence of insomnia in patients with chronic back pain. J. Orthop. Surg. (Hong Kong) 2013, 21:68-70.
94. Yamashita A., et al. Astrocytic activation in the anterior cingulate cortex is critical for sleep disorder under neuropathic pain. Synapse 2014, 68:235-247.
95. Imai S., et al. Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J. Neurosci. 2011, 31:15294-15299.
96. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 2013, 14:609-625.
97. LaPlant Q., et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat. Neurosci. 2010, 13:1137-1143.
98. Navratilova E., Porreca F. Reward and motivation in pain and pain relief. Nat. Neurosci. 2014, 17:1304-1312.
99. Chaplan S.R., et al. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53:55-63.
100. Vadakkan K.I., et al. A behavioral model of neuropathic pain induced by ligation of the common peroneal nerve in mice. J. Pain 2005, 6:747-756.
101. Toyoda H., et al. Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain. Mol. Pain 2009, 5:4.
102. Barrot M. Tests and models of nociception and pain in rodents. Neuroscience 2012, 211:39-50.
103. Hargreaves K., et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
104. Deuis J.R., et al. An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways. Pain 2013, 154:1749-1757.
105. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
106. Crepaldi L., Riccio A. Chromatin learns to behave. Epigenetics 2009, 4:23-26.
107. Kress M., et al. microRNAs in nociceptive circuits as predictors of future clinical applications. Front. Mol. Neurosci. 2013, 6:33.
108. Lin Y.C., et al. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. Brain Res. 2008, 1246:1-10.